Hotchkis & Wiley Capital Management LLC lessened its stake in shares of Herbalife Ltd (NYSE:HLF - Free Report) by 66.0% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 922,610 shares of the company's stock after selling 1,786,980 shares during the period. Hotchkis & Wiley Capital Management LLC owned approximately 0.91% of Herbalife worth $7,962,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its position in shares of Herbalife by 10.9% during the first quarter. Vanguard Group Inc. now owns 12,495,374 shares of the company's stock valued at $107,835,000 after buying an additional 1,223,957 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its position in shares of Herbalife by 13.4% during the first quarter. Charles Schwab Investment Management Inc. now owns 3,057,219 shares of the company's stock valued at $26,384,000 after buying an additional 360,659 shares during the last quarter. Iridian Asset Management LLC CT boosted its position in shares of Herbalife by 10.7% during the first quarter. Iridian Asset Management LLC CT now owns 2,775,430 shares of the company's stock valued at $23,952,000 after buying an additional 267,690 shares during the last quarter. Jacobs Levy Equity Management Inc. boosted its position in shares of Herbalife by 67.0% during the fourth quarter. Jacobs Levy Equity Management Inc. now owns 2,570,226 shares of the company's stock valued at $17,195,000 after buying an additional 1,031,078 shares during the last quarter. Finally, Northern Trust Corp boosted its position in shares of Herbalife by 14.5% during the fourth quarter. Northern Trust Corp now owns 1,002,676 shares of the company's stock valued at $6,708,000 after buying an additional 126,902 shares during the last quarter.
Herbalife Price Performance
Shares of HLF traded up $0.62 during trading hours on Friday, hitting $9.79. The stock had a trading volume of 3,073,314 shares, compared to its average volume of 1,915,601. Herbalife Ltd has a 12 month low of $5.04 and a 12 month high of $10.83. The firm has a market capitalization of $1.01 billion, a PE ratio of 3.09, a PEG ratio of 0.30 and a beta of 0.85. The stock has a fifty day moving average price of $9.38 and a 200 day moving average price of $8.17.
Herbalife (NYSE:HLF - Get Free Report) last released its quarterly earnings results on Wednesday, August 6th. The company reported $0.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.53 by $0.06. Herbalife had a negative return on equity of 27.36% and a net margin of 6.59%.The business had revenue of $1.26 billion during the quarter, compared to analyst estimates of $1.27 billion. During the same quarter in the previous year, the company posted $0.54 earnings per share. Herbalife's revenue for the quarter was down 1.7% on a year-over-year basis. As a group, analysts anticipate that Herbalife Ltd will post 1.57 EPS for the current fiscal year.
Analyst Ratings Changes
HLF has been the topic of several recent analyst reports. Mizuho increased their price objective on Herbalife from $8.00 to $9.00 and gave the company a "neutral" rating in a research report on Monday, July 28th. Wall Street Zen lowered shares of Herbalife from a "strong-buy" rating to a "buy" rating in a research note on Sunday, August 10th. Three investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $11.50.
Read Our Latest Analysis on HLF
About Herbalife
(
Free Report)
Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.
Read More

Before you consider Herbalife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Herbalife wasn't on the list.
While Herbalife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.